Atossa Therapeutics (ATOS) Other Operating Expenses (2011 - 2017)
Atossa Therapeutics (ATOS) posted quarterly Other Operating Expenses of $461715.0 for Q4 2017, up 97.62% quarter-over-quarter from $233632.0 in Q4 2015.
Atossa Therapeutics (ATOS) Other Operating Expenses (2011 - 2017) Analysis & Trends
Atossa Therapeutics (ATOS) has reported Other Operating Expenses for 6 consecutive years, with $461715.0 the latest figure, recorded in Q4 2017.
- In Q4 2017, Other Operating Expenses changed N/A year-over-year to $461715.0; the TTM figure through Sep 2018 stood at $461715.0 (changed N/A YoY), while the FY2017 annual figure was $461715.0, up 382.68% from the prior year.
- Other Operating Expenses grew to $461715.0 in Q4 2017 per ATOS's latest filing, from $233632.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $2.3 million in Q4 2014 and bottomed at $223385.0 in Q2 2014.
- Historically, Other Operating Expenses has averaged $476113.1 across 4 years, with a median of $319390.0 in 2013.
- Annual changes were most pronounced in 2014 — Other Operating Expenses jumped 688.27% — and 2015, when it plunged 89.86%.
- Atossa Therapeutics' Other Operating Expenses stood at $292408.0 in 2013, then surged by 688.27% to $2.3 million in 2014, then slumped by 89.86% to $233632.0 in 2015, then soared by 97.62% to $461715.0 in 2017.
- Business Quant data shows ATOS's Other Operating Expenses at $461715.0 in Q4 2017, $233632.0 in Q4 2015, and $498609.0 in Q3 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Atossa Therapeutics | 22.63 Mn | 22.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 461,715.00 |
| Dec 31, 2015 | 233,632.00 |
| Sep 30, 2015 | 498,609.00 |
| Jun 30, 2015 | 343,322.00 |
| Mar 31, 2015 | 345,845.00 |
| Dec 31, 2014 | 2.30 Mn |
| Sep 30, 2014 | 282,374.00 |
| Jun 30, 2014 | 223,385.00 |
| Mar 31, 2014 | 237,838.00 |
| Dec 31, 2013 | 292,408.00 |
| Sep 30, 2013 | 373,418.00 |
| Jun 30, 2013 | 319,390.00 |
| Mar 31, 2013 | 272,575.00 |
| Dec 31, 2012 | 184,850.00 |
| Sep 30, 2012 | 87,704.00 |
| Jun 30, 2012 | 123,832.00 |
| Mar 31, 2012 | 70,435.00 |
| Dec 31, 2011 | 160,851.00 |